HOME >> MEDICINE >> NEWS
Baltimore researchers receive $40 million from Bill & Melinda Gates Foundation

Johns Hopkins School of Public Health and University of Maryland School of Medicine to develop ground-breaking measles vaccine for infants in developing countries

The Bill & Melinda Gates Foundation has awarded grants of $20 million each to the University of Maryland School of Medicine and the Johns Hopkins University School of Public Health to develop a new type of measles vaccine that, for the first time, would protect infants younger than 9 months old. Such a vaccine would dramatically reduce the suffering and death rate from measles in developing countries.

"Finding a safe and effective vaccine to protect the world's youngest children against measles is an urgent global health priority," says Bill Foege, Senior Health Advisor at the Bill & Melinda Gates Foundation. "We are tremendously hopeful that this collaboration between two major research facilities will speed the development of this important vaccine and ultimately help save millions of children's lives."

Measles kills more than 900,000 children each year in less developed parts of the world, according to the World Health Organization (WHO). While widespread use of the current injected measles vaccine has saved the lives of millions of children, the disease is far from being eradicated in the developing world because a window of vulnerability exists among infants from 5 to 8 months of age.

Newborns are protected against measles by antibodies passed to them from their mothers, but those antibody levels drop steadily over time, increasing the infants' susceptibility to measles. At the same time, low levels of the mother's antibodies neutralize the effectiveness of the measles vaccine. For that reason, the WHO recommends that the current measles vaccine be administered when children are at least 9 months old.

"We are pleased that the Bill & Melinda Gates Foundation has asked us to take on this ambitious, five-year project. It will involve laboratory work as well as cl
'"/>

Contact: Dennis O'Shea
dro@jhu.edu
410-516-7109
Johns Hopkins University
27-Aug-2000


Page: 1 2 3 4

Related medicine news :

1. Impact of 2002 Canadian forest fires felt 700 miles away in Baltimore, Maryland
2. HIV infection rate and risky behavior decline amoung injection drug users in Baltimore
3. Indiana University researchers closer to helping hearing-impaired using stem cells
4. Protein that helps skin cancer spread identified by Stanford researchers
5. US life expectancy about to decline, researchers say
6. Gene for age-related macular degeneration discovered by Yale researchers
7. Dartmouth researchers find where musical memories are stored in the brain
8. Columbia researchers receive $3 million to combat genetic killer of infants & toddlers
9. US cancer researchers launch first American-Israeli cancer conference
10. USC dental researchers develop first test for predicting cavities in children
11. Young blood revives aging muscles, Stanford researchers find

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2017)... Somerset, N.J. (PRWEB) , ... September 25, 2017 ... ... advanced delivery technologies and development solutions for drugs, biologics and consumer health products, ... workshops on the development and validation of bioassays at two upcoming conferences. , ...
(Date:9/25/2017)... , ... September 25, 2017 , ... ... affiliated with NCPDP, announced today that it has awarded a $40,000 grant to ... NCPDP’s SCRIPT Standard for ePrescribing. CancelRx enables prescribers to electronically cancel a prescription ...
(Date:9/25/2017)... (PRWEB) , ... September 25, 2017 , ... ... to improve quality and efficiency. The principle of First-Defect-Stop for laboratory weighing ... results before they have the chance to have negative consequences on downstream processes. ...
(Date:9/25/2017)... Doylestown, Pa. (PRWEB) , ... ... ... world-leading provider of specialized science and technology-enabled services supporting clinical research, today ... of topics addressing key aspects of the drug development lifecycle at upcoming ...
(Date:9/25/2017)... (PRWEB) , ... September 25, 2017 , ... ... why retirement is not an option to senior, upper-level executives speaking at a ... , "A senior, high-level executive is an asset to be fully realized ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... NEW YORK , Sept. 8, 2017 ... largest independent supplier of medical equipment, supplies, drugs, ... that it has entered into an agreement to acquire ... surgical equipment based in Holtsville, New York ... which specializes in supplying new and emerging medical practices, ...
(Date:9/7/2017)... , Sept. 7, 2017  For nearly two decades, New Life Agency ... Assisted Reproduction Insurance industry. Today, New Life Agency announces a powerful three-way ... ... ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
(Date:9/7/2017)... WARSAW, Ind. , Sept. 7, 2017  Zimmer ... leader in musculoskeletal healthcare, today announced that it will ... Annual Global Healthcare Conference at the Grand Hyatt hotel ... September 11, 2017 at 11:40 a.m. Eastern Time. ... accessed via Zimmer Biomet,s Investor Relations website at ...
Breaking Medicine Technology:
Cached News: